xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

734

International consensus statement on rhinosinusitis

2491. Parma V, Ohla K, Veldhuizen MG, et al. More than smell– COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses . 2020;45(7):609-622. 2492. Jiramongkolchai P, Peterson A, Kallogjeri D, et al. Random ized clinical trial to evaluate mometasone lavage vs spray for patients with chronic rhinosinusitis without nasal polyps who have not undergone sinus surgery. Int Forum Allergy Rhinol . 2020;10(8):936-943. 2493. Sweis AM, Locke TB, Douglas JE, et al. Management of chronic rhinosinusitis with steroid nasal irrigations: a viable nonsurgical alternative in the COVID-19 era. Int Forum Allergy Rhinol . 2020;10(9):1108-1109. 2494. Khan MM, Parab SR, Paranjape M. Repurposing 0.5% povi done iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol . 2020;41(5):102618. 2495. Lee VS, Pottinger PS, Davis GE. Tolerability and effective ness of povidone-iodine or mupirocin versus saline sinus irrigations for chronic rhinosinusitis. Am J Otolaryngol . 2020:41(5):102604. 2496. Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR. Consideration of povidone-iodine as a public health intervention for COVID-19: utilization as “Personal Protec tive Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol . 2020;105:104724. 2497. Frank S, Capriotti J, Brown SM, Tessema B. Povidone-iodine use in sinonasal and oral cavities: a review of safety in the COVID-19 era. Ear Nose Throat J . 2020:99(9):586-593. 2498. Anderson DE, Sivalingam V, Kang AEZ, et al. Povidone-iodine demonstrates rapid in-vitro virucidal activity against SARS CoV-2, the virus causing COVID-19 disease. Infect Dis Ther . 2020;9(3):669-675. 2499. Ramaswamykanive H, Nanavati Z, Mackie J, Linderman R, Lavee O. Cardiovascular collapse following povidone-iodine wash. Anaesth Intensive Care . 2011;39(1):127-130. 2500. Förster-Ruhrmann U, Szczepek AJ, Bachert C, Olze H. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab. J Allergy Clin Immunol . 2020;146(1):218-220.e212. 2501. Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement. Allergy . 2020;75(11):2764-2774.

2476. Prajapati DP, Shahrvini B, MacDonald B, et al. Association of subjective olfactory dysfunction and 12-item odor identi fication testing in ambulatory COVID-19 patients. Int Forum Allergy Rhinol . 2020;10(11):1209-1217. 2477. Lechien JR, Ducarme M, Place S, et al. Objective olfactory findings in hospitalized severe COVID-19 patients. Pathogens . 2020;9(8):627. 2478. Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: single-center experience on 72 cases. HeadNeck . 2020;42(6):1252-1258. 2479. Hintschich CA, Wenzel JJ, Hummel T, et al. Psychophysi cal tests reveal impaired olfaction but preserved gustation in COVID-19 patients. Int Forum Allergy Rhinol . 2020;10(9):1105 1107. 2480. Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol . 2020;10(7):821 831. 2481. Paderno A, Schreiber A, Grammatica A, et al. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol . 2020;10(8):955-962. 2482. Hopkins C, Vaira LA, De Riu G. Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor? IntForum Allergy Rhinol . 2020;10(7):926. 2483. Yan CH, Faraji F, DeConde AS. Reply to: self-reported olfac tory loss in COVID-19: is it really a favorable prognostic factor? Int Forum Allergy Rhinol . 2020;10(7):927-928. 2484. Vaira LA, Hopkins C, Petrocelli M, et al. Do olfactory and gus tatory psychophysical scores have prognostic value in COVID 19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surgy . 2020;49(1):1-10. 2485. Le Bon SD, Pisarski N, Verbeke J, et al. Psychophysical eval uation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients. Eur Arch Otorhinolaryngol . 2021;278(1):101-108. 2486. Chiesa-Estomba CM, Lechien JR, Radulesco T, et al. Patterns of smell recovery in 751 patients affected by the COVID-19 out break. Eur J Neurol . 2020;27(11):2318-2321. 2487. Hopkins C, Surda P, Whitehead E, Kumar BN. Early recov ery following new onset anosmia during the COVID-19 pandemic–an observational cohort study. J Otolaryngol Head NeckSurg . 2020;49(1):26. 2488. Yan CH, Prajapati DP, Ritter ML, DeConde AS. Persistent smell loss following undetectable SARS-CoV-2. Otolaryngol Head Neck Surg . 2020;163(5):923-925. 2489. Huart C, Philpott C, Konstantinidis I, et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhi nology . 2020;58(6):623-625. 2490. Giuseppe M, Fabio F, Armando DV, et al. Prevalence of taste and smell dysfunction in coronavirus disease 2019. JAMAOto laryngol Head Neck Surg . 2020;146(8):1-6

How to cite this article: Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on rhinology and allergy: rhinosinusitis. Int Forum Allergy Rhinol . 2021;11:213–739. https://doi.org/10.1002/alr.22741